Log in to save to my catalogue

Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to mala...

Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to mala...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4511589

Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites

About this item

Full title

Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites

Publisher

England: BioMed Central Ltd

Journal title

Malaria journal, 2015-07, Vol.14 (1), p.285-285, Article 285

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The estimates of risk of malaria in early childhood are imprecise given the current entomologic and parasitological tools. Thus, the utility of anti-Anopheles salivary gSG6-P1 peptide antibody responses in measuring exposure to Anopheles bites during early infancy has been assessed.
Anti-gSG6-P1 IgG and IgM levels were evaluated in 133 infants (...

Alternative Titles

Full title

Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4511589

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4511589

Other Identifiers

ISSN

1475-2875

E-ISSN

1475-2875

DOI

10.1186/s12936-015-0800-6

How to access this item